Orthopediatrics (KIDS) Superinvestor holders
10 of the superinvestors we track hold Orthopediatrics (KIDS) in their latest 13F filings, $27M in total.
Summary
The largest holder is Wasatch (Wasatch Global Investors), with $10M, 0.1% of the portfolio.
In their latest quarter: 2 opened a new position, 5 added, 3 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Wasatch Wasatch Global Investors |
Trimmed | 469,449 | $10M | 0.1% | Q3 2026 |
| Wilmot Harkey Nantahala Capital Management |
Added | 242,342 | $5M | 0.3% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 170,022 | $3M | 0.0% | Q2 2026 |
| Eddie Brown Brown Capital Management |
Trimmed | 89,203 | $2M | 0.4% | Q3 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 91,415 | $2M | 0.0% | Q2 2026 |
| Conestoga Conestoga Capital Advisors |
Added | 74,975 | $2M | 0.1% | Q3 2026 |
| Acadian Acadian Asset Management |
Added | 71,748 | $2M | 0.0% | Q3 2026 |
| Cliff Asness AQR Capital Management |
New position | 78,291 | $1M | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 23,126 | $442,400 | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
New position | 10,598 | $202,740 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 10 |
| Q1 2026 | 8 |
| Q4 2025 | 8 |
| Q3 2025 | 7 |
| Q2 2025 | 6 |
| Q1 2025 | 6 |
| Q4 2024 | 6 |
| Q3 2024 | 6 |
Questions about Orthopediatrics
Which superinvestors own Orthopediatrics?
10 of the superinvestors we track hold Orthopediatrics (KIDS) in their latest 13F filings, $27M in total. Wasatch, Wilmot Harkey, Paul Tudor Jones, Eddie Brown, David Shaw, Conestoga.
Who is the largest superinvestor holder of KIDS?
The largest holder is Wasatch (Wasatch Global Investors), with $10M, 0.1% of the portfolio.
From Orthopediatrics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.